Elias Mai

47PUBLICATIONS
218CO-AUTHORS
Nuclear physicsGene and molecular therapyMedical mycologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|Jun 25, 2026
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|Mar 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma.

Floris Chabrun, Daniel E Schwartz, Susanna Gentile

|Dec 22, 2025
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

Martin Grözinger, Muriel Schlanke, Jana Gröne

|Nov 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.

Tim Richardson, Elias Mai, Ekaterina Menis

Pageof 8

Frequent Collaborators

27 joint publications

Hartmut Goldschmidt

21 joint publications

Marc S Raab

12 joint publications

Katja Weisel

11 joint publications

Niels Weinhold